Roger D. Dansey

Insider Reports History

Entity
Individual
Location
21823 30 Th Drive Se, Bothell, WA
Signature
/s/ Allison Frisbee, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Roger D. Dansey:

Stock Role Class Num Shares Value Price $ Report Date Ownership
INOVIO PHARMACEUTICALS, INC. Director Common Stock 6.75K $88.2K $13.07 May 15, 2024 Direct
INOVIO PHARMACEUTICALS, INC. Director Restricted Stock Unit 2.17K $28.3K $13.07 May 21, 2024 Direct
Kronos Bio, Inc. Director Stock Option (Right to Buy) 34K Jun 25, 2024 Direct
INOVIO PHARMACEUTICALS, INC. Director Common Stock Options 2.92K May 21, 2024 Direct
Seagen Inc. President, R&D & CMO Common Stock 0 $229.00 Dec 14, 2023 Direct
Seagen Inc. President, R&D & CMO Performance Stock Units 0 $229.00 Dec 14, 2023 Direct
Seagen Inc. President, R&D & CMO Restricted Stock Units 0 $229.00 Dec 14, 2023 Direct
Seagen Inc. President, R&D & CMO Stock Options (Right to Buy) 0 Dec 14, 2023 Direct

Insider Reports Filed by Roger D. Dansey

Symbol Company Period Transactions Value $ Form Type Date Filed Role
KRON Kronos Bio, Inc. Jun 25, 2024 1 $0 4 Jun 26, 2024 Director
INO INOVIO PHARMACEUTICALS, INC. May 21, 2024 2 $0 4 May 22, 2024 Director
INO INOVIO PHARMACEUTICALS, INC. May 15, 2024 2 $0 4 May 16, 2024 Director
INO INOVIO PHARMACEUTICALS, INC. May 13, 2024 2 $0 4 May 13, 2024 Director
SGEN Seagen Inc. Dec 14, 2023 28 -$8.78M 4 Dec 15, 2023 President, R&D & CMO
SGEN Seagen Inc. Aug 31, 2023 1 -$834K 4 Sep 1, 2023 President, R&D & CMO
SGEN Seagen Inc. Aug 28, 2023 2 -$209K 4 Aug 30, 2023 President, R&D & CMO
SGEN Seagen Inc. Aug 15, 2023 4 -$1.99M 4 Aug 17, 2023 President, R&D & CMO
KRON Kronos Bio, Inc. Jun 22, 2023 1 $0 4 Jun 26, 2023 Director
INO INOVIO PHARMACEUTICALS, INC. May 13, 2023 6 $0 4 May 16, 2023 Director
KRON Kronos Bio, Inc. Apr 20, 2023 1 $0 4 Apr 24, 2023 Director
KRON Kronos Bio, Inc. Apr 20, 2023 0 $0 3 Apr 24, 2023 Director
SGEN Seagen Inc. Apr 17, 2023 3 -$1.33M 4 Apr 19, 2023 President, R&D & CMO
SGEN Seagen Inc. Apr 5, 2023 0 $0 4/A Apr 12, 2023 President, R&D & CMO
SGEN Seagen Inc. Apr 1, 2023 1 $0 4 Apr 4, 2023 President, R&D & CMO
SGEN Seagen Inc. Mar 15, 2023 3 -$1.27M 4 Mar 17, 2023 President, R&D & CMO
SGEN Seagen Inc. Mar 13, 2023 3 -$14.7K 4 Sep 22, 2023 President, R&D & CMO
SGEN Seagen Inc. Feb 15, 2023 5 -$680K 4 Feb 17, 2023 President, R&D & CMO
SGEN Seagen Inc. Feb 2, 2023 1 -$108K 4 Feb 3, 2023 President, R&D & CMO
SGEN Seagen Inc. Jan 24, 2023 3 -$624K 4 Jan 26, 2023 President, R&D & CMO
SGEN Seagen Inc. Jan 4, 2023 6 -$624K 4 Jan 6, 2023 President R&D & CMO
SGEN Seagen Inc. Dec 14, 2022 6 -$578K 4 Dec 16, 2022 President, Research and Develo
SGEN Seagen Inc. Nov 9, 2022 1 $0 4 Nov 14, 2022 President, Research & Development & Chief Medical Officer
SGEN Seagen Inc. Oct 17, 2022 9 -$605K 4 Oct 19, 2022 Interim CEO & CMO
SGEN Seagen Inc. Aug 31, 2022 3 -$775K 4 Sep 1, 2022 Interim CEO & CMO
SGEN Seagen Inc. Aug 15, 2022 3 -$724K 4 Aug 17, 2022 Interim CEO & CMO
SGEN Seagen Inc. Jun 28, 2022 13 -$4.95M 4 Jun 30, 2022 Chief Medical Officer
INO INOVIO PHARMACEUTICALS, INC. May 13, 2022 4 $0 4 May 17, 2022 Director
SGEN Seagen Inc. Apr 20, 2022 2 -$208K 4 Apr 22, 2022 Chief Medical Officer
SGEN Seagen Inc. Feb 2, 2022 2 -$197K 4 Feb 4, 2022 Chief Medical Officer
SGEN Seagen Inc. Jan 3, 2022 3 -$1.32M 4 Jan 5, 2022 Chief Medical Officer
SGEN Seagen Inc. Dec 20, 2021 2 -$85.5K 4 Dec 22, 2021 Chief Medical Officer
SGEN Seagen Inc. Sep 23, 2021 2 $595K 4 Sep 27, 2021 Chief Medical Officer
SGEN Seagen Inc. Aug 31, 2021 3 -$772K 4 Sep 2, 2021 Chief Medical Officer
SGEN Seagen Inc. Aug 16, 2021 4 -$256K 4 Aug 18, 2021 Chief Medical Officer
SGEN Seagen Inc. Aug 13, 2021 2 -$1.57M 4 Aug 13, 2021 Chief Medical Officer
SGEN Seagen Inc. Jun 16, 2021 1 -$3.82M 4 Jun 21, 2021 Chief Medical Officer
INO INOVIO PHARMACEUTICALS, INC. May 13, 2021 2 $0 4 May 17, 2021 Director
INO INOVIO PHARMACEUTICALS, INC. May 13, 2021 0 $0 3 May 17, 2021 Director